Podcast
The Uromigos
Hosted by The Uromigos · EN
Broadcasting the latest developments in GU cancer
Hosted by Brian Rini and Tom Powles
Brian Rini MD is an Ingram Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center
Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London
492episodes
Episodes
Newest firstAll episodes
Episode 445: ESMO 2025 - Systemic Checkpoint Inhibition plus BCG in NMIBC (POTOMAC and ALBAN)
Oct 1700:36:54Tap to summarizeBrad McGregor joins us on the heels of his #ESMO25 discussion of these important data in the NMIBC landscape.
Transcribe →Episode 444: ESMO 2025 Preview - Prostate and Renal Cancer
Oct 800:41:58Tap to summarizeSilke joins us to discuss some important data being presented in prostate cancer. Brian and Tom also cover the RCC data at ESMO 2025
Transcribe →Episode 443: ESMO 2025 Bladder Cancer Preview
Oct 200:32:09Tap to summarizeTom and Brian preview the practice-changing bladder cancer data to be presented at ESMO 2025 in Berlin
Transcribe →Episode 441: The History of IO in Urothelial Cancer - Part 2
Sep 2900:33:16Tap to summarizeJonathan Rosenberg returns to finish this two-part series on IO drug development in urothelial cancer
Transcribe →Episode 440: The History of IO in Urothelial Cancer - Part 1
Sep 2200:45:39Tap to summarizeJonathan Rosenberg joins in this 2-part series on the history of IO-based therapy in Urothelial Cancer
Transcribe →Episode 439: Transcriptome Expression and Treatment Sensitivity in Prostate Cancer
Sep 1500:41:24Tap to summarizeGert Attard joins the show to discuss his recent Cell publication looking at tumor transcriptome-wide expression classifiers in advanced prostate cancer.
Transcribe →Episode 438: The History of Testis Cancer Treatment
Sep 800:39:22Tap to summarizeChristian Kollmannsberger joins us to walk through decades of advances in advanced testis cancer.
Transcribe →Episode 437: Uromigos Japan - バルバーサ (Erdafitinib)を実臨床でどう使うか！
Sep 100:44:36Tap to summarizeErdafitinibがついに承認されましたが、依然として多くのCQが残されています。日常診療に役立つ最新のデータをもとに、その活用法についてディスカッションしました。
Transcribe →Episode 436: The History of IO in RCC - Part 2
Aug 2500:36:29Tap to summarizeWe continue our conversation with Mike Atkins and David McDermott, discussing IO-based combination therapy in RCC.
Transcribe →Episode 435: The History of IO in RCC - Part 1
Aug 1800:27:52Tap to summarizeThe fathers of IO therapy in RCC - Michael Atkins and David McDermott - join us to take a tour through IO development in RCC over the last 20 years.
Transcribe →